Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115966615 | 11596661 | 5 | F | 20150825 | 20160725 | 20151006 | 20160801 | EXP | PHHY2015GB117229 | SANDOZ | 0.00 | Y | 0.00000 | 20160801 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115966615 | 11596661 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG, QD | U | U | UNK | 75757 | 40 | MG | QD | ||||
| 115966615 | 11596661 | 2 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, QD | Y | U | 0 | 40 | MG | QD | |||||
| 115966615 | 11596661 | 3 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, QD | Y | U | UNK | 0 | 40 | MG | QD | ||||
| 115966615 | 11596661 | 4 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, UNK | Y | U | 0 | 20 | MG | ||||||
| 115966615 | 11596661 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1400 MG, QD | 7000 | MG | U | U | 0 | 1400 | MG | QD | |||
| 115966615 | 11596661 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1400 MG, QD | 7000 | MG | U | U | UNK | 0 | 1400 | MG | QD | ||
| 115966615 | 11596661 | 7 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 100 MG, QD | 500 | MG | U | U | 0 | 100 | MG | QD | |||
| 115966615 | 11596661 | 8 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 100 MG, QD | 500 | MG | U | U | UNK | 0 | 100 | MG | QD | ||
| 115966615 | 11596661 | 9 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 2 MG, QD | 10 | MG | U | U | UNK | 0 | 2 | MG | QD | ||
| 115966615 | 11596661 | 10 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 375 MG/M2, QD | 3600 | MG | U | U | 0 | 375 | MG/M**2 | QD | |||
| 115966615 | 11596661 | 11 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | DAY 1 | 3600 | MG | U | U | 0 | 375 | MG/M**2 | QD | |||
| 115966615 | 11596661 | 12 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 720 MG, QD | 3600 | MG | U | U | UNK | 0 | 720 | MG | QD | ||
| 115966615 | 11596661 | 13 | SS | INOTUZUMAB OZOGAMICIN | INOTUZUMAB OZOGAMICIN | 1 | Intravenous (not otherwise specified) | 1.5 MG, QD | 6 | MG | UNK | 0 | 1.5 | MG | QD | ||||
| 115966615 | 11596661 | 14 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, QD | 3000 | MG | U | 0 | 300 | MG | QD | ||||
| 115966615 | 11596661 | 15 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 75 MG, QD | U | 0 | 75 | MG | QD | ||||||
| 115966615 | 11596661 | 16 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 125 UG, QD | U | 0 | 125 | UG | QD | ||||||
| 115966615 | 11596661 | 17 | C | DIGOXIN. | DIGOXIN | 1 | Unknown | U | 0 | ||||||||||
| 115966615 | 11596661 | 18 | C | FILGRASTIM | FILGRASTIM | 1 | Subcutaneous | 300 UG, QD | 600 | UG | U | 0 | 300 | UG | QD | ||||
| 115966615 | 11596661 | 19 | C | FILGRASTIM | FILGRASTIM | 1 | Subcutaneous | 300 UG, QD | 600 | UG | U | 0 | 300 | UG | QD | ||||
| 115966615 | 11596661 | 20 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 50 MG, QD | 500 | MG | U | 0 | 50 | MG | QD | ||||
| 115966615 | 11596661 | 21 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Oral | 200 MG, BID | 4400 | MG | U | 0 | 200 | MG | BID | ||||
| 115966615 | 11596661 | 22 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Oral | 20 MG. QD | U | 0 | 20 | MG | QD | ||||||
| 115966615 | 11596661 | 23 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Oral | 20 MG | U | 0 | 20 | MG | |||||||
| 115966615 | 11596661 | 24 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Oral | 10 MG, | U | 0 | 10 | MG | |||||||
| 115966615 | 11596661 | 25 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Oral | DOSE: 10-20 MG | U | 0 | |||||||||
| 115966615 | 11596661 | 26 | C | ONDANSETRON | ONDANSETRON | 1 | Oral | 8 MG, QD | 40 | MG | U | 0 | 8 | MG | QD | ||||
| 115966615 | 11596661 | 27 | C | CHLORPHENAMINE | CHLORPHENIRAMINE MALEATE | 1 | Intravenous (not otherwise specified) | 10 MG, QD | 50 | MG | Y | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115966615 | 11596661 | 1 | Gastrointestinal haemorrhage |
| 115966615 | 11596661 | 2 | Cardiac disorder |
| 115966615 | 11596661 | 5 | Neoplasm malignant |
| 115966615 | 11596661 | 6 | Diffuse large B-cell lymphoma |
| 115966615 | 11596661 | 7 | Diffuse large B-cell lymphoma |
| 115966615 | 11596661 | 9 | Diffuse large B-cell lymphoma |
| 115966615 | 11596661 | 10 | Diffuse large B-cell lymphoma |
| 115966615 | 11596661 | 13 | Diffuse large B-cell lymphoma |
| 115966615 | 11596661 | 14 | Prophylaxis |
| 115966615 | 11596661 | 15 | Aortic valve replacement |
| 115966615 | 11596661 | 16 | Atrial fibrillation |
| 115966615 | 11596661 | 18 | White blood cell count |
| 115966615 | 11596661 | 20 | Antifungal prophylaxis |
| 115966615 | 11596661 | 21 | Rheumatoid arthritis |
| 115966615 | 11596661 | 22 | Rheumatoid arthritis |
| 115966615 | 11596661 | 23 | Vomiting |
| 115966615 | 11596661 | 26 | Vomiting |
| 115966615 | 11596661 | 27 | Unevaluable event |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115966615 | 11596661 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115966615 | 11596661 | Blood lactic acid increased | |
| 115966615 | 11596661 | Hyponatraemia | |
| 115966615 | 11596661 | Lower respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115966615 | 11596661 | 1 | 20150826 | 0 | ||
| 115966615 | 11596661 | 3 | 20150826 | 0 | ||
| 115966615 | 11596661 | 6 | 20150820 | 20150820 | 0 | |
| 115966615 | 11596661 | 8 | 20150820 | 20150824 | 0 | |
| 115966615 | 11596661 | 9 | 20150820 | 20150820 | 0 | |
| 115966615 | 11596661 | 10 | 20150820 | 20150820 | 0 | |
| 115966615 | 11596661 | 11 | 20150820 | 20150820 | 0 | |
| 115966615 | 11596661 | 12 | 20150820 | 20150820 | 0 | |
| 115966615 | 11596661 | 13 | 20150821 | 20150821 | 0 | |
| 115966615 | 11596661 | 14 | 20150815 | 20150826 | 0 | |
| 115966615 | 11596661 | 15 | 20150826 | 0 | ||
| 115966615 | 11596661 | 16 | 20150826 | 0 | ||
| 115966615 | 11596661 | 17 | 20150815 | 20150826 | 0 | |
| 115966615 | 11596661 | 18 | 20150815 | 20150826 | 0 | |
| 115966615 | 11596661 | 19 | 20150823 | 20150826 | 0 | |
| 115966615 | 11596661 | 20 | 20150815 | 20150826 | 0 | |
| 115966615 | 11596661 | 21 | 20150814 | 20150826 | 0 | |
| 115966615 | 11596661 | 22 | 201107 | 20150826 | 0 | |
| 115966615 | 11596661 | 23 | 20150820 | 20150826 | 0 | |
| 115966615 | 11596661 | 24 | 20150820 | 20150826 | 0 | |
| 115966615 | 11596661 | 25 | 20150820 | 20150826 | 0 | |
| 115966615 | 11596661 | 26 | 20150820 | 20150820 | 0 | |
| 115966615 | 11596661 | 27 | 20150820 | 20150820 | 0 |